Masaki Yamasaki

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados et al. · The Lancet Neurology · 2018 · 177 citations · Full text

The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force

Qingbo S. Wang, Ryuya Edahiro, Ho Namkoong et al. · Nature Communications · 2022 · 48 citations · Full text

Classification of acute pain trajectory after breast cancer surgery identifies patients at risk for persistent pain: a prospective observational study

Akiko Okamoto, Masaki Yamasaki, Isao Yokota et al. · Journal of Pain Research · 2018 · 47 citations · Full text

Risk factors and prognosis of pain events during mechanical ventilation: a retrospective study

Ayahiro Yamashita, Masaki Yamasaki, Hiroki Matsuyama et al. · Journal of Intensive Care · 2017 · 34 citations · Full text

Addition of cilostazol to aspirin therapy for secondary prevention of cardiovascular and cerebrovascular disease in patients undergoing percutaneous coronary intervention: A randomized, open-label trial

Hiroshi Ueda, Atsumichi Kido, Seiji Matsuhisa et al. · American Heart Journal · 2015 · 21 citations

Percutaneous Coronary Intervention, Thrombosis, Open-label Trial +12